Application 091019
- Type
- ANDA
- Sponsor
- NEXGEN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CHENODIOL | CHENODIOL | TABLET;ORAL | 250MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091019-001 | CHENODIOL | CHENODIOL | 250MG | TABLET / ORAL | RS | 2009-10-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091019-001 | CHENODIOL | 250MG | TABLET / ORAL | RS | 2009-10-22 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chenodal | CHENODIOL | Travere Therapeutics | 769e0a3b-826d-4faf-9129-5eeb7ebe0b67 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 091019 ANDA091019 68974-876 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0722-7121 | Chenodiol | Chenodiol | Nexgen Pharma, Inc. | ANDA | Current |
| 0722-7121 | Chenodiol | Chenodiol | Nexgen Pharma, Inc. | ANDA | Current |
| 45043-876 | Chenodal | Chenodiol | Manchester Pharmaceuticals Inc. | ANDA | Current |
| 68974-876 | Chenodal | Chenodiol | Retrophin, Inc. | ANDA | Current |
| 68974-876 | Chenodal | Chenodiol | Retrophin, Inc. | ANDA | Current |
| 68974-876 | Chenodal | Chenodiol | Retrophin, Inc. | ANDA | Current |
| 68974-876 | Chenodal | Chenodiol | Retrophin, Inc. | ANDA | Current |
| 68974-876 | Chenodal | Chenodiol | Retrophin, Inc. | ANDA | Current |
| 68974-876 | Chenodal | Chenodiol | Travere Therapeutics | ANDA | Current |
| 79739-7121 | Chenodiol | Chenodiol | LGM Pharma Solutions, LLC | ANDA | Current |